An Exploratory, Multicenter, Single-blind, fMRI Study of Fixed-dose Brexpiprazole (OPC-34712) (2 mg/day tablets) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Irritability
|Effective start/end date||7/1/14 → 9/1/15|
- OTSUKA PHARMACEUTICAL CO., LTD.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.